Dilsaver Evelyn S 4

What Happened
Evelyn Dilsaver, a director of QuidelOrtho Corporation (QDEL), received an award of 15,532 restricted stock units (RSUs) on June 25, 2026. The RSUs were granted with no purchase price ($0.00) and are reported as a derivative award. Each RSU represents the right to receive one share of common stock when vested.

Key Details

• Transaction date: 2026-06-25 (Form 4 filed 2026-06-29).
• Instrument: 15,532 restricted stock units (derivative award) at $0.00 per unit.
• Vesting: RSUs vest on June 25, 2027 (footnote).
• Shares owned after transaction: Not specified in the provided filing.
• Footnotes: F1—each RSU equals one share upon settlement; F2—vesting date 6/25/2027.
• Filing timeliness: Form 4 reflects the June 25 grant and was submitted on June 29, 2026 (no late-filing flag shown in supplied data).

Context
This is a typical equity-compensation grant to a board director (part of compensation, not an open-market purchase or sale). Awards like RSUs do not require out-of-pocket payment by the insider and only convert to actual shares if and when they vest; they are therefore not a direct trading signal.